Bendamustine – USA

Bendamustine – USA

On Aug. 13, 2021, Federal Circuit affirmed (Rule 36 judgment) district court’s decision of infringement in Bendeka® case.

 

You can read the district court decision summary here.”

 

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Disclaimer
All content provided on this blog is for informational purposes only. By using the blog, you agree that the information on this blog does not constitute legal or other professional advice on author's or on his company's behalf.

Copyrights 2023 Pharma IP Circle. All Rights Reserved